Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 22067393

Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2012 Jan 20
First author
Marin D

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2012 Jan 20;30(3):223-4. doi: 10.1200/JCO.2011.39.6655.
    note
    Source null
    related pmid
    22184376
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2012 Apr 1;30(10):1144-5; author reply 1145-6. doi: 10.1200/JCO.2011.41.1090.
    note
    Source null
    related pmid
    22393079
    relationship
    Comment in

Authors and identifiers

  1. name
    Marin D
    type
    Author
  2. name
    Ibrahim AR
    type
    Author
  3. name
    Lucas C
    type
    Author
  4. name
    Gerrard G
    type
    Author
  5. name
    Wang L
    type
    Author
  6. name
    Szydlo RM
    type
    Author
  7. name
    Clark RE
    type
    Author
  8. name
    Apperley JF
    type
    Author
  9. name
    Milojkovic D
    type
    Author
  10. name
    Bua M
    type
    Author
  11. name
    Pavlu J
    type
    Author
  12. name
    Paliompeis C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Marin D
    type
    Author
  2. name
    Ibrahim AR
    type
    Author
  3. name
    Lucas C
    type
    Author
  4. name
    Gerrard G
    type
    Author
  5. name
    Wang L
    type
    Author
  6. name
    Szydlo RM
    type
    Author
  7. name
    Clark RE
    type
    Author
  8. name
    Apperley JF
    type
    Author
  9. name
    Milojkovic D
    type
    Author
  10. name
    Bua M
    type
    Author
  11. name
    Pavlu J
    type
    Author
  12. name
    Paliompeis C
    type
    Author
bibliography ids
  1. nci-bib-9510141cb7abc2d837109708
book metadata
content sha256
530ae87a8ba5d89254412ca049b2ae9854648d1c3656eac0000a0e4dfadbad87
document type
citation
dois
  1. 10.1200/JCO.2011.38.6565
electronic publication date
display
2011 Nov 7
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:22067393
immutable id
pubmed:22067393@530ae87a8ba5d89254412ca049b2ae9854648d1c3656eac0000a0e4dfadbad87
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
3
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
232-8
volume
30
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2012 Jan 20;30(3):223-4. doi: 10.1200/JCO.2011.39.6655.
    note
    Source null
    related pmid
    22184376
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2012 Apr 1;30(10):1144-5; author reply 1145-6. doi: 10.1200/JCO.2011.41.1090.
    note
    Source null
    related pmid
    22393079
    relationship
    Comment in
outcomes validated
false
pmid
22067393
provenance
batch id
2529ef2eca926738ab13
provider
NCBI PubMed ESummary
record sha256
0cee9f3f50e4871b431e3f5d5f73cf6c7f05ccd3024606b60ca0b0ec11d0cbd6
response sha256
9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
retrieved at
2026-09-09T23:46:42.856296+00:00
publication date
display
2012 Jan 20
precision
day
year
2012
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/22067393/
title
Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Preserved source evidence · Not medical advice